Nabil specialises in IP and regulatory advice for clients ranging from start-ups to global players, with a particular focus on the life sciences and other technology-rich sectors.
Nabil provides pragmatic, commercially-minded advice with a focus on intellectual property strategy and regulatory compliance.
In addition to advice on the identification, protection, commercialisation and enforcement of IP rights, Nabil supports clients with commercial contracts, due diligence, and regulatory compliance. With experience from working in-house and in private practice, for commercial and public sector clients, as well as in legal and non-legal roles, Nabil brings an outcomes focus to his advice which his clients appreciate.
Prior to training as a solicitor, Nabil worked in early phase pharmaceutical R&D for AstraZeneca and chaired the Physical Organic Chemistry Group of the Royal Society of Chemistry. Nabil has a Ph.D. in Chemistry from Cambridge University and spent a year and a half undertaking post-doctoral research at the University of Groningen on how the crowded environment of a biological cell impacts the chemistry going on inside it, before moving to a commercial-sector role in fine chemicals manufacturing. He is corresponding author on a number of scientific papers in leading international journals.
|Since 2020||Associate, Taylor Wessing|
|2018 - 2020||Associate, Eversheds Sutherland|
|2016 - 2017||Senior solicitor, Hempsons|
|2014 - 2016||In-house counsel, International Procurement and Logistics|
|2012 - 2014||Trainee, Kempner & Partners|
|2005 - 2008||Associate team leader, AstraZeneca|
|2003 - 2005||R&D chemist, Avecia|
|2001 - 2003||Post-Doctoral Research Fellow, University of Groningen|
|2014||Admitted as a solicitor|
|2013||LLM, BPP Law School|
|2011||LPC, BPP Law School|
|2010||GDL, BPP Law School|
|2002||PhD, Cambridge University|
|1997||BSc (Hons) Medicinal Chemistry, University of Leeds|
par plusieurs auteurs